Table 3 Description of comorbidity in the population according to the Elixhauser score and Elixhauser-lung
From: Comparison of seven comorbidity scores on four-month survival of lung cancer patients
Population (n = 633) | Elixhauser | Elixhauser-lung |
|---|---|---|
Congestive Heart Failure | 46 (7.3) | 46 (7.3) |
Cardiac arrythmias | 77 (12.2) | |
Vascular disease | 22 (3.5) | 22 (3.5) |
Pulmonary circulation disorders | 40 (6.3) | 40 (6.3) |
Peripheral vascular disorders | 48 (7.6) | 48 (7.6) |
Paralysis | 46 (7.3) | 46 (7.3) |
Neurodegenerative disorders | 42 (6.6) | 42 (6.6) |
Chronic pulmonary disease | 91 (14.4) | 91 (14.4) |
Renal failure | 26 (4.1) | 26 (4.1) |
Liver disease | 19 (3.0) | |
Lymphoma | 4 (0.6) | |
Cancer* | 65 (10.3) | |
Coagulopathy | 27 (4.3) | 27 (4.3) |
Obesity | 11 (1.7) | 11 (1.7) |
Weight loss | 345 (54.5) | 345 (54.5) |
Fluid and electrolyte disorders | 91 (14.4) | |
Blood loss anemia | 6 (1.0) | |
Deficiency anemia | 14 (2.2) | |
Drug abuse | 8 (1.3) | |
Depression | 29 (4.6) | 29 (4.6) |
Diabetes with complications | 11 (1.7) | |
Hypothyroidism | 17 (2.7) | |
Rheumatological disorders | 4 (0.6) | |
Psychosis | 9 (1.4) |